0.40
-0.0316(-7.34%)
Currency In USD
| Previous Close | 0.43 |
| Open | 0.43 |
| Day High | 0.43 |
| Day Low | 0.4 |
| 52-Week High | 3.6 |
| 52-Week Low | 0.28 |
| Volume | 974,040 |
| Average Volume | 12.51M |
| Market Cap | 17.64M |
| PE | -0.3 |
| EPS | -1.31 |
| Moving Average 50 Days | 0.43 |
| Moving Average 200 Days | 1.34 |
| Change | -0.03 |
If you invested $1000 in Harvard Bioscience, Inc. (HBIO) 10 years ago, it would be worth $77.33 as of July 15, 2025 at a share price of $0.399. Whereas If you bought $1000 worth of Harvard Bioscience, Inc. (HBIO) shares 5 years ago, it would be worth $113.68 as of July 15, 2025 at a share price of $0.399.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Harvard Bioscience Appoints John Duke to Board of Directors
GlobeNewswire Inc.
Jun 02, 2025 8:57 PM GMT
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and no
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
GlobeNewswire Inc.
May 05, 2025 8:45 PM GMT
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss
Harvard Bioscience Announces CFO Transition
GlobeNewswire Inc.
Apr 10, 2025 8:45 PM GMT
HOLLISTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Jennifer Cote, the Company’s Chief Financial Officer and Treasurer. Ms. Cote’s resignation will be effec